China strength signals progress, but valuation still demands proof

What happened

Barron's highlights improving China business and analyst upside, which aligns with the DeepValue report's watch item for Asia/China trajectory. However, underlying financials remain stressed: FY2025 swung to a $0.8B operating loss and $1.1B net loss, with free cash flow compressed and net debt/EBITDA at ~34x. PRGP restructuring has shown early success with Q1 FY2026 positive operating income and margin improvement, yet the stock trades at EV/EBITDA ~214x and a DCF fair value far below the current price. The market has already priced in a rapid turnaround, as evidenced by the ~29% 12-month share price increase. Until we see sustained mid-single-digit revenue growth, structurally lower SG&A, and deleveraging, the risk/reward for new capital remains unattractive, consistent with a WAIT stance.

Implication

The reported China improvement is directionally positive for the turnaround thesis, but it is one data point against a backdrop of high leverage and still-loss-making GAAP earnings. Manageable near-term triggers include holiday and Chinese New Year trading to confirm the China trend, and quarterly evidence that PRGP savings are structurally lowering SG&A. If China sales and margins continue to improve while gross margin holds near 73-75%, it would support a more constructive stance, but current valuation already assumes much of this. Conversely, if China strength proves transitory or travel retail (ex-daigou) fails to normalize, the stock has significant downside given its stretched multiples and balance-sheet fragility. Position accordingly: treat EL as a watchlist name; only consider adding on a meaningful pullback to a price that embeds a credible FCF recovery, or after several quarters of confirmed execution.

Thesis delta

The China commentary from Barron's introduces a mildly positive signal on a key turnaround metric, but it does not yet alter the fundamental risk/reward calculus. The DeepValue stance of WAIT remains appropriate until there is consistent evidence that China growth is sustainable and translates into free cash flow and leverage improvement. Any upgrade would require mid-single-digit revenue growth, structurally improved margins, and net debt/EBITDA trending toward single digits.